http://www.fiveprime.com
Five Prime Therapeutics, Inc. Company Intro
Five Prime's comprehensive discovery platform positions it to explore pathways in cancer, inflammation and their intersection in immuno-oncology.
Industry
Healthcare
Five Prime Therapeutics, Inc. Headquaters
111 Oyster Point Boulevard
South San Francisco,94080
United States
Five Prime Therapeutics, Inc. Share price
22 Oct 2020 01:40 GMT
$5.67
-0.01 (-0.18 %)
Five Prime Therapeutics, Inc. Market cap
$201.087 M
WMC RANKING
2020
Five Prime Therapeutics, Inc. # 135
BiotechnologyLatest Five Prime Therapeutics, Inc. News
21 Oct 2020
Global T Cell Specific Surface Glycoprotein CD28 Market ...
Five Prime Therapeutics Inc ... For instance, the company can be profiled you ask for while specific region/country analysis can be focused that meets your ...
21 Oct 2020
Squamous Non-Small Cell Lung Cancer Therapeutics Market ...
BIND Therapeutics Inc. Boehringer Ingelheim GmbH. Bristol-Myers Squibb Company Eli Lilly and Company F. Hoffmann-La Roche Ltd. Five Prime Therapeutics ...
22 Oct 2020
Latest Update 2020: What Are the Key Players Evolving In the ...
... population aged over 65 from 8% to 24% in China and 5% to 12% in India. ... Radius Health Inc., Five Prime Therapeutics, Inc., Abbott Laboratories, Pfizer Inc., ...
WMC Market Score
WMC Market to Revenue Score
| Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score | |
| Five Prime Therapeutics, Inc. | 0.28 | 0.22 | 0 | 0 | 0 | 0 | 0.17 |
| Alexion Pharmaceuticals, Inc. | 100 | 13.19 | 100 | 19 | 0 | 0 | 98.79 |
| Vertex Pharmaceuticals Incorporated | 97.58 | 100 | 4.12 | 30 | 0 | 0 | 100 |
| 3SBio Inc. | 96.05 | 0 | 0 | 4 | 0 | 0 | 3.02 |
| Incyte Corporation | 40.27 | 14.26 | 7.26 | 100 | 0 | 0 | 90.93 |
Five Prime Therapeutics, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Five Prime Therapeutics, Inc. | $15,695 | $165,815 | $-144,598 | $201.087M | 135 |
| Alexion Pharmaceuticals, Inc. | $5,536,800 | $2,523,000 | $846,100 | $25.904B | 1 |
| Vertex Pharmaceuticals Incorporated | $5,402,685 | $2,634,428 | $2,080,775 | $55.058B | 2 |
| 3SBio Inc. | ¥5,318,091 | ¥3,085,221 | ¥973,717 | ¥19.953B | 3 |
| Incyte Corporation | $2,229,409 | $1,622,822 | $446,906 | $19.377B | 4 |